title: [Clinical observations using the new contraceptive preparation containing gestagen].
abstract: 31 women aged 26-35 were observed during hormonal contraception with Femovan (in Poland registered as Femoden). The aim of the study was an analysis of effectiveness, influence on menstrual cycles and adverse effects in Femovan users. The conclusions of the study indicated that Femovan is very effective in contraception (Pearl index = 0). It provides good cycle control. It reduced in 50% women nausea and breast tenderness which occurred before starting of contraception. There were not body gain and elevated blood pressure in any women. Acne was reduced in 40% women after 3 months of using.
mesh_terms: D000152:Acne Vulgaris / Q000517:prevention & control; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects; D009325:Nausea / Q000517:prevention & control; D009652:Norpregnenes / Q000494:pharmacology*
chemical_list: D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D009652:Norpregnenes; C055368:Femovan; D004997:Ethinyl Estradiol
vernacular_title: Obserwacje kliniczne stosowania nowego preparatu antykoncepcyjnego za wierajacego gestoden.